Antipodes Partners’s American Tower AMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$73.4M Buy
448,574
+11,628
+3% +$2.09M 1.34% 34
2026
Q1
$75.4M Buy
436,946
+29,789
+7% +$5.36M 1.45% 34
2025
Q4
$71.5M Buy
407,157
+52,573
+15% +$9.57M 1.5% 29
2025
Q3
$68.2M Buy
+354,584
New +$73.9M 1.53% 28

Other funds holding AMT

Antipodes Partners's AMT Position: Q2 2026 in Review

Antipodes Partners increased its American Tower (AMT) stake by 2.7% in Q2 2026, buying an estimated $2.09M and bringing the position to 448,574 shares worth $73.4M. The position accounts for 1.34% of the portfolio, ranked #34.

Antipodes Partners first reported a position in AMT in Q3 2025 and has held it in 4 quarters since. The position peaked at $75.4M in Q1 2026. 1,758 funds tracked by Wall St. Rank hold AMT as of Q2 2026.

  • Antipodes Partners held 448,574 shares of American Tower worth $73.4M as of Q2 2026.
  • Antipodes Partners bought 11,628 American Tower shares in Q2 2026, an estimated $2.09M.
  • American Tower made up 1.34% of Antipodes Partners's portfolio in Q2 2026, its #34 holding.
  • Antipodes Partners first reported a position in American Tower in Q3 2025 and has held it in 4 quarters since.
  • Antipodes Partners's American Tower position peaked at $75.4M in Q1 2026.
  • 1,758 funds tracked by Wall St. Rank held American Tower as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.